We are live on ! Find out more
VYNE icon

VYNE Therapeutics
VYNE

104 hedge funds and large institutions have $138M invested in VYNE Therapeutics in 2020 Q4 according to their latest regulatory filings, with 18 funds opening new positions, 37 increasing their positions, 23 reducing their positions, and 19 closing their positions.

New
Increased
Maintained
Reduced
Closed

61% more repeat investments, than reductions

Existing positions increased: 37 | Existing positions reduced: 23

5% more capital invested

Capital invested by funds: $132M → $138M (+$6.25M)

0.07% more ownership

Funds ownership: 0.66% → 0.73% (+0.07%)

0% more funds holding in top 10

Funds holding in top 10: 2 → 2 (0)

1% less funds holding

Funds holding: 105 → 104 (-1)

5% less first-time investments, than exits

New positions opened: 18 | Existing positions closed: 19

Holders
104
Holders Change
-1
Holders Change %
-0.95%
% of All Funds
1.84%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.04%
New
18
Increased
37
Reduced
23
Closed
19
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
BlackRock
BlackRock
New York
+$3.74M
2
DAM
Deltec Asset Management
New York
+$3.66M
3
Two Sigma Investments
Two Sigma Investments
New York
+$1.05M
4
Squarepoint
Squarepoint
New York
+$874K
5
State Street
State Street
Massachusetts
+$866K

Top Sellers

Rank Fund Capital Flow
1
VC
Vivo Capital
California
-$1.54M
2
MIM
Monashee Investment Management
Massachusetts
-$581K
3
Point72 Asset Management
Point72 Asset Management
Connecticut
-$352K
4
Morgan Stanley
Morgan Stanley
New York
-$277K
5
SSA
Schonfeld Strategic Advisors
New York
-$256K
Name Holding Trade Value Shares
Change 		Change in
Stake
SC
26
Saltoro Capital
Texas
$571K +$631K +5,021 New
Charles Schwab
27
Charles Schwab
California
$565K – – –
SCM
28
Silverarc Capital Management
Massachusetts
$552K +$610K +4,856 New
FMBTD
29
First Midwest Bank Trust Division
Illinois
$471K +$520K +4,138 New
California Public Employees Retirement System
30
California Public Employees Retirement System
California
$467K -$10.9K -87 -2%
PVH
31
Psagot Value Holdings
Israel
$427K – – –
Connor, Clark & Lunn Investment Management (CC&L)
32
Connor, Clark & Lunn Investment Management (CC&L)
British Columbia, Canada
$411K +$105K +832 +30%
California State Teachers Retirement System (CalSTRS)
33
California State Teachers Retirement System (CalSTRS)
California
$347K – – –
State of Wisconsin Investment Board
34
State of Wisconsin Investment Board
Wisconsin
$322K +$55K +438 +18%
Ameriprise
35
Ameriprise
Minnesota
$303K -$76.9K -612 -19%
SFI
36
Susquehanna Fundamental Investments
Pennsylvania
$294K -$125K -991 -28%
PAM
37
Premier Asset Management
Illinois
$289K +$320K +2,544 New
RhumbLine Advisers
38
RhumbLine Advisers
Massachusetts
$286K +$60.7K +483 +24%
Goldman Sachs
39
Goldman Sachs
New York
$278K +$147K +1,171 +92%
Morgan Stanley
40
Morgan Stanley
New York
$256K -$277K -2,207 -50%
UBS Group
41
UBS Group
Switzerland
$236K +$97.6K +777 +60%
Russell Investments Group
42
Russell Investments Group
United Kingdom
$205K +$188K +1,493 +474%
Wells Fargo
43
Wells Fargo
California
$200K +$30.2K +240 +16%
CL
44
CSS LLC
Illinois
$183K -$17.5K -139 -8%
AllianceBernstein
45
AllianceBernstein
Tennessee
$179K -$45.1K -359 -19%
Deutsche Bank
46
Deutsche Bank
Germany
$163K +$52.8K +420 +41%
New York State Common Retirement Fund
47
New York State Common Retirement Fund
New York
$154K – – –
PTP
48
Platform Technology Partners
New York
$153K -$39.2K -312 -19%
Manulife (Manufacturers Life Insurance)
49
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$147K +$19.7K +157 +14%
PPA
50
Parametric Portfolio Associates
Washington
$133K -$29.3K -233 -17%
1
2
3 4 5

VYNE Hedge Fund Activity: Q4 2020 in Review

104 of the 5,651 institutional investors tracked by Wall St. Rank reported a position in VYNE Therapeutics (VYNE) for Q4 2020, worth a combined $138M — up 4.7% from $132M a quarter earlier.

Sellers outnumbered buyers: 19 funds closed out of VYNE and 18 opened new positions — a net loss of 1 holder — while 23 trimmed existing stakes and 37 added.

The largest buyer was BlackRock, adding an estimated $3.74M. The largest seller was Vivo Capital, cutting an estimated $1.54M.

  • 104 institutional investors held VYNE Therapeutics (VYNE) as of Q4 2020, down from 105 in Q3 2020.
  • Funds reported $138M of VYNE Therapeutics stock for Q4 2020, up 4.7% quarter-over-quarter.
  • 18 funds opened new VYNE Therapeutics positions in Q4 2020 and 19 closed out, a net change of -1 holder.
  • The largest VYNE Therapeutics buyer in Q4 2020 was BlackRock, an estimated $3.74M added.
  • The largest VYNE Therapeutics seller in Q4 2020 was Vivo Capital, an estimated $1.54M sold.

Based on aggregated 13F filings for Q4 2020.